newsfilter
← Latest News
Business Wire·

Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Kezar Life Sciences, Inc. (NASDAQ:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Co-founder